HGF has one of the largest and most experienced pharmaceutical patent attorney/lawyer teams in Europe. Many of our attorneys and solicitors have joined from large pharmaceutical companies and bring extensive in-house experience of building, managing enforcing and defending global patent portfolios protecting some of the highest profile medicines in Europe.
Our multidisciplinary team supports clients through all stages of the development and lifespan of a pharmaceutical product. We specialise in providing IP strategy advice, invention capture, drafting and filing patent applications, patent prosecution, infringement analysis, EPO oppositions/appeals, commercialisation across the life cycle and multi-jurisdictional patent litigation. We also have specialist experience of supplementary protection certificates (SPCs), regulatory data exclusivity and IP due diligence. A large part of our pharmaceutical practice involves contentious proceedings in the courts and at the EPO. A number of our experienced patent attorneys specialise in opposition and appeal proceedings before the European Patent Office and are regularly involved with complex and high-value multi-party oppositions. Our team of solicitors, working together with our patent attorneys, are also regularly involved in high-profile pharmaceutical patent disputes i nthe national Courts and across Europe.
In terms of technical expertise, our multidisciplinary team specialises in IP relating to drug compounds, particular forms of drug compounds (salt, solvates and polymorphs), formulations (including advanced drug delivery systems), processes for making drug compounds, methods of treatment and therapeutic uses (including drug repositioning), dosage regimens, combination therapies, drug conjugates (such as antibody drug conjugates and PROTACs) and neutraceuticals.
We’ve built our business by recruiting and developing specialists, not generalists. When it comes to protecting your ideas and business, you want to know you’re working with the best – people who truly understand your sector and the potential of your IP.
HGF’s team has pharmaceuticals professionals from an array of academic and business backgrounds. Our team-based approach ensures our clients benefit from the very best strategic advice from people who understand not only the legal environment but also the practical side of your business.
Looking forward to 'The future of Innovation: Your #data' event hosted by @nexusunileeds on 21 Sept, where a panel of speakers (including HGF's Senior IP Solicitor James Talbot) will discuss #consumerdata. Find out more here: lnkd.in/dD3t6SwD #DataProtection https://t.co/juprEK2cM4Follow HGF on Twitter
In a Judgment handed down on 21 September 2021 ( EWCA Civ 1374), the Court of Appeal has rejected an appeal by Dr. Stephen Thaler claiming that it should have …Read article
HGF is sponsoring The Business of Science Conference 2021 on 7th October. Science and the commercialisation of science continues to be fundamental to the economic growth of the UK and …Event details
How has the luxury industry adapted to the new realities of the last 18 months? #LuxuryLawSummit Europe on 22 Sept will cover this and more different topics related to the industry. Join HGF in our workshop on 'Ecommerce, reseller platforms and upcycling': hgf.com/events/luxury-… https://t.co/kWZIev5F9BFollow HGF on Twitter